<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4e67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="20" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="11" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font13" size="6" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font14" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font16" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font17" size="10" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font18" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font19" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font20" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font21" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font22" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font23" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="16" height="9" font="font0" id="p1_t1" reading_order_no="2" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="44" left="525" width="22" height="9" font="font1" id="p1_t2" reading_order_no="3" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="44" left="548" width="27" height="9" font="font3" id="p1_t3" reading_order_no="4" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/">Central</a></text>
<text top="756" left="508" width="46" height="10" font="font4" id="p1_t4" reading_order_no="81" segment_no="26" tag_type="text">Page 1 of 9</text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t5" reading_order_no="82" segment_no="27" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="19" left="55" width="337" height="19" font="font6" id="p1_t6" reading_order_no="0" segment_no="0" tag_type="title"><b>Epidemiologic Perspectives &amp; </b></text>
<text top="39" left="55" width="129" height="19" font="font6" id="p1_t7" reading_order_no="1" segment_no="0" tag_type="title"><b>Innovations</b></text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="title"><a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="87" left="55" width="73" height="13" font="font8" id="p1_t9" reading_order_no="6" segment_no="3" tag_type="title">Methodology</text>
<text top="105" left="55" width="451" height="15" font="font9" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="title"><b>New patient-oriented summary measure of net total gain in </b></text>
<text top="123" left="55" width="315" height="15" font="font9" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="title"><b>certainty for dichotomous diagnostic tests</b></text>
<text top="140" left="55" width="70" height="14" font="font10" id="p1_t12" reading_order_no="9" segment_no="5" tag_type="text">Shai Linn*</text>
<text top="140" left="125" width="6" height="10" font="font11" id="p1_t13" reading_order_no="10" segment_no="5" tag_type="text">1</text>
<text top="140" left="131" width="134" height="14" font="font10" id="p1_t14" reading_order_no="11" segment_no="5" tag_type="text"> and Peter D Grunau</text>
<text top="140" left="265" width="6" height="10" font="font11" id="p1_t15" reading_order_no="12" segment_no="5" tag_type="text">2</text>
<text top="176" left="55" width="31" height="8" font="font12" id="p1_t16" reading_order_no="13" segment_no="6" tag_type="text">Address: </text>
<text top="175" left="86" width="3" height="5" font="font13" id="p1_t17" reading_order_no="14" segment_no="6" tag_type="text">1</text>
<text top="176" left="89" width="465" height="8" font="font12" id="p1_t18" reading_order_no="15" segment_no="6" tag_type="text">Faculty of Social Welfare and Health Studies, School of Public Health, University of Haifa, and Unit of Clinical Epidemiology, Rambam </text>
<text top="185" left="55" width="115" height="8" font="font12" id="p1_t19" reading_order_no="16" segment_no="6" tag_type="text">Medical Center, Haifa, Israel and </text>
<text top="185" left="171" width="3" height="5" font="font13" id="p1_t20" reading_order_no="17" segment_no="6" tag_type="text">2</text>
<text top="185" left="174" width="275" height="8" font="font12" id="p1_t21" reading_order_no="18" segment_no="6" tag_type="text">Faculty of Medicine, the University of British Columbia, Vancouver BC, Canada</text>
<text top="200" left="55" width="317" height="8" font="font12" id="p1_t22" reading_order_no="19" segment_no="7" tag_type="text">Email: Shai Linn* - linn@tx.technion.ac.il; Peter D Grunau - pdgrunau@interchange.ubc.ca</text>
<text top="211" left="55" width="92" height="8" font="font12" id="p1_t23" reading_order_no="20" segment_no="8" tag_type="text">* Corresponding author  <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17022816">  </a></text>
<text top="359" left="112" width="44" height="10" font="font14" id="p1_t24" reading_order_no="33" segment_no="16" tag_type="title"><b>Abstract</b></text>
<text top="374" left="112" width="53" height="9" font="font15" id="p1_t25" reading_order_no="34" segment_no="17" tag_type="text"><b>Objectives: </b></text>
<text top="374" left="167" width="330" height="9" font="font16" id="p1_t26" reading_order_no="35" segment_no="17" tag_type="text">To introduce a new, patient-oriented predictive index as a measure of gain in</text>
<text top="386" left="112" width="37" height="9" font="font16" id="p1_t27" reading_order_no="36" segment_no="17" tag_type="text">certainty.</text>
<text top="403" left="112" width="63" height="9" font="font15" id="p1_t28" reading_order_no="37" segment_no="18" tag_type="text"><b>Study design: </b></text>
<text top="403" left="175" width="79" height="9" font="font16" id="p1_t29" reading_order_no="38" segment_no="18" tag_type="text">Algebraic equations.</text>
<text top="419" left="112" width="38" height="9" font="font15" id="p1_t30" reading_order_no="39" segment_no="19" tag_type="text"><b>Results: </b></text>
<text top="419" left="151" width="346" height="9" font="font16" id="p1_t31" reading_order_no="40" segment_no="19" tag_type="text">A new measure is suggested based on error rates in a patient population. The new</text>
<text top="431" left="112" width="386" height="9" font="font16" id="p1_t32" reading_order_no="41" segment_no="19" tag_type="text">Predictive Summary Index (PSI) reflects the true total gain in certainty obtained by performing a</text>
<text top="443" left="112" width="386" height="9" font="font16" id="p1_t33" reading_order_no="42" segment_no="19" tag_type="text">diagnostic test based on knowledge of disease prevalence, i.e., the overall additional certainty. We</text>
<text top="455" left="112" width="386" height="9" font="font16" id="p1_t34" reading_order_no="43" segment_no="19" tag_type="text">show that the overall gain in certainty can be expressed in the form of the following expression:</text>
<text top="466" left="112" width="386" height="9" font="font16" id="p1_t35" reading_order_no="44" segment_no="19" tag_type="text">PSI = PPV+NPV-1. PSI is a more comprehensive measure than the post-test probability or the</text>
<text top="478" left="112" width="61" height="9" font="font16" id="p1_t36" reading_order_no="45" segment_no="19" tag_type="text">Youden Index (</text>
<text top="478" left="173" width="2" height="9" font="font17" id="p1_t37" reading_order_no="46" segment_no="19" tag_type="text"><i>J</i></text>
<text top="478" left="175" width="79" height="9" font="font16" id="p1_t38" reading_order_no="47" segment_no="19" tag_type="text">). The reciprocal of </text>
<text top="478" left="254" width="5" height="9" font="font17" id="p1_t39" reading_order_no="48" segment_no="19" tag_type="text"><i>J </i></text>
<text top="478" left="259" width="238" height="9" font="font16" id="p1_t40" reading_order_no="49" segment_no="19" tag_type="text">is interpreted as the number of persons with a given disease</text>
<text top="490" left="112" width="385" height="9" font="font16" id="p1_t41" reading_order_no="50" segment_no="19" tag_type="text">who need to be examined in order to detect correctly one person with the disease. The reciprocal</text>
<text top="502" left="112" width="386" height="9" font="font16" id="p1_t42" reading_order_no="51" segment_no="19" tag_type="text">of PSI is suggested as the number of persons who need to be examined in order to correctly predict</text>
<text top="513" left="112" width="101" height="9" font="font16" id="p1_t43" reading_order_no="52" segment_no="19" tag_type="text">a diagnosis of the disease.</text>
<text top="530" left="112" width="56" height="9" font="font15" id="p1_t44" reading_order_no="53" segment_no="20" tag_type="text"><b>Conclusion: </b></text>
<text top="530" left="169" width="151" height="9" font="font16" id="p1_t45" reading_order_no="54" segment_no="20" tag_type="text">PSI provides more information than </text>
<text top="530" left="320" width="5" height="9" font="font17" id="p1_t46" reading_order_no="55" segment_no="20" tag_type="text"><i>J </i></text>
<text top="530" left="326" width="171" height="9" font="font16" id="p1_t47" reading_order_no="56" segment_no="20" tag_type="text">and the predictive values, making it more</text>
<text top="542" left="112" width="122" height="9" font="font16" id="p1_t48" reading_order_no="57" segment_no="20" tag_type="text">appropriate in a clinical setting.</text>
<text top="591" left="55" width="60" height="10" font="font14" id="p1_t49" reading_order_no="58" segment_no="21" tag_type="title"><b>Background</b></text>
<text top="603" left="55" width="241" height="9" font="font18" id="p1_t50" reading_order_no="59" segment_no="23" tag_type="text">The main justification for performing a diagnostic test is</text>
<text top="614" left="55" width="241" height="9" font="font18" id="p1_t51" reading_order_no="60" segment_no="23" tag_type="text">to gain new information [<a href="">1-3], beyon</a>d the existing prob-</text>
<text top="626" left="55" width="241" height="9" font="font18" id="p1_t52" reading_order_no="61" segment_no="23" tag_type="text">ability (the prevalence) obtained from a positive test, i.e.,</text>
<text top="638" left="55" width="241" height="9" font="font18" id="p1_t53" reading_order_no="62" segment_no="23" tag_type="text">prevalence minus the positive predictive value (PPV) and</text>
<text top="650" left="55" width="241" height="9" font="font18" id="p1_t54" reading_order_no="63" segment_no="23" tag_type="text">from a negative test, i.e., (1-prevalence) minus the nega-</text>
<text top="662" left="55" width="241" height="9" font="font18" id="p1_t55" reading_order_no="64" segment_no="23" tag_type="text">tive predictive value (NPV). We introduce a predictive</text>
<text top="673" left="55" width="241" height="9" font="font18" id="p1_t56" reading_order_no="65" segment_no="23" tag_type="text">summary index (PSI), a new measure that summarizes the</text>
<text top="685" left="55" width="241" height="9" font="font18" id="p1_t57" reading_order_no="66" segment_no="23" tag_type="text">total gain in certainty, i.e., the overall additional certainty,</text>
<text top="697" left="55" width="241" height="9" font="font18" id="p1_t58" reading_order_no="67" segment_no="23" tag_type="text">expressed as PSI = PPV+NPV-1. We show that the recipro-</text>
<text top="709" left="55" width="241" height="9" font="font18" id="p1_t59" reading_order_no="68" segment_no="23" tag_type="text">cal of PSI can be interpreted as the number of persons</text>
<text top="720" left="55" width="241" height="9" font="font18" id="p1_t60" reading_order_no="69" segment_no="23" tag_type="text">needed to be examined in order to correctly predict a diag-</text>
<text top="591" left="313" width="241" height="9" font="font18" id="p1_t61" reading_order_no="70" segment_no="22" tag_type="text">nosis of the disease (NNP). We compare the PSI with a</text>
<text top="603" left="313" width="241" height="9" font="font18" id="p1_t62" reading_order_no="71" segment_no="22" tag_type="text">less informative summary measure of a test in a limited</text>
<text top="614" left="313" width="171" height="9" font="font18" id="p1_t63" reading_order_no="72" segment_no="22" tag_type="text">study population, the Youden Index (</text>
<text top="614" left="484" width="3" height="9" font="font19" id="p1_t64" reading_order_no="73" segment_no="22" tag_type="text"><i>J</i></text>
<text top="614" left="487" width="67" height="9" font="font18" id="p1_t65" reading_order_no="74" segment_no="22" tag_type="text">), proposed by</text>
<text top="626" left="313" width="241" height="9" font="font18" id="p1_t66" reading_order_no="75" segment_no="22" tag_type="text">Youden<a href=""> [1] as a </a>measure of the goodness of a diagnostic</text>
<text top="638" left="313" width="17" height="9" font="font18" id="p1_t67" reading_order_no="76" segment_no="22" tag_type="text">test.</text>
<text top="662" left="313" width="233" height="9" font="font20" id="p1_t68" reading_order_no="77" segment_no="24" tag_type="title"><i><b>The terminology of diagnostic test<a href=""> characteristics [4-29]</a></b></i></text>
<text top="673" left="313" width="241" height="9" font="font18" id="p1_t69" reading_order_no="78" segment_no="25" tag_type="text">Performance assessment of a dichotomous diagnostic test</text>
<text top="685" left="313" width="241" height="9" font="font18" id="p1_t70" reading_order_no="79" segment_no="25" tag_type="text">is usually based on assessing test performances in two dif-</text>
<text top="697" left="313" width="80" height="9" font="font18" id="p1_t71" reading_order_no="80" segment_no="25" tag_type="text">ferent populations.</text>
<text top="254" left="55" width="91" height="7" font="font21" id="p1_t72" reading_order_no="21" segment_no="9" tag_type="text">Published: 05 October 2006</text>
<text top="268" left="55" width="123" height="7" font="font22" id="p1_t73" reading_order_no="22" segment_no="12" tag_type="text"><i>Epidemiologic Perspectives &amp; Innovations</i></text>
<text top="268" left="178" width="22" height="7" font="font21" id="p1_t74" reading_order_no="23" segment_no="12" tag_type="text"> 2006, </text>
<text top="268" left="200" width="4" height="7" font="font23" id="p1_t75" reading_order_no="24" segment_no="12" tag_type="text"><b>3</b></text>
<text top="268" left="204" width="10" height="7" font="font21" id="p1_t76" reading_order_no="25" segment_no="12" tag_type="text">:11</text>
<text top="268" left="223" width="92" height="7" font="font21" id="p1_t77" reading_order_no="26" segment_no="12" tag_type="text">doi:10.1186/1742-5573-3-11</text>
<text top="254" left="335" width="84" height="7" font="font21" id="p1_t78" reading_order_no="31" segment_no="10" tag_type="text">Received: 09 August 2005</text>
<text top="263" left="335" width="91" height="7" font="font21" id="p1_t79" reading_order_no="32" segment_no="11" tag_type="text">Accepted: 05 October 2006</text>
<text top="282" left="55" width="251" height="7" font="font21" id="p1_t80" reading_order_no="27" segment_no="13" tag_type="text"><a href="http://www.epi-perspectives.com/content/3/1/11">This article is available from: http://www.epi-perspectives.com/content/3/1/11</a></text>
<text top="297" left="55" width="181" height="7" font="font21" id="p1_t81" reading_order_no="28" segment_no="14" tag_type="text">Â© 2006 Linn and Grunau; licensee BioMed Central Ltd. </text>
<text top="306" left="55" width="492" height="7" font="font21" id="p1_t82" reading_order_no="29" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens<a href="http://creativecommons.org/licenses/by/2.0">e (http://creativecommons.org/licenses/by/2.0), </a></text>
<text top="315" left="55" width="400" height="7" font="font21" id="p1_t83" reading_order_no="30" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
